<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>4005</number>
    <updateDate>2024-07-24T15:21:38Z</updateDate>
    <updateDateIncludingText>2024-07-24T15:21:38Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2023-06-12</introducedDate>
    <congress>118</congress>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 169, Number 102 (Monday, June 12, 2023)][House]From the Congressional Record Online through the Government Publishing Office [<a href="https://www.gpo.gov">www.gpo.gov</a>]By Ms. KUSTER:H.R. 4005.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 1 of the United StatesConstitution, the Taxing and Spending Clause: ``The Congressshall have Power To lay and collect Taxes, Duties, Impostsand Excises, to pay the Debts and provide for the commonDefense and general Welfare of the United States . . .''The single subject of this legislation is:This bill would require a study on the affordability andaccessibility of naloxone.[Page H2809]</pre>]]></constitutionalAuthorityStatementText>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2023-06-16T18:17:34Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2023-06-12T16:00:10Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>STOP Fentanyl Overdoses Act of 2023</title>
        <congress>118</congress>
        <number>3375</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2023-05-19</actionDate>
          <text>Referred to the Subcommittee on Health.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Pharmacy Benefit Manager Reform Act</title>
        <congress>118</congress>
        <number>1339</number>
        <type>S</type>
        <latestAction>
          <actionDate>2023-06-22</actionDate>
          <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 113.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Stop Fentanyl Overdoses Act of 2023</title>
        <congress>118</congress>
        <number>1785</number>
        <type>S</type>
        <latestAction>
          <actionDate>2023-05-31</actionDate>
          <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2023-06-16</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2023-06-12</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2023-06-12</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2023-06-12</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>K000382</bioguideId>
        <fullName>Rep. Kuster, Ann M. [D-NH-2]</fullName>
        <firstName>Ann</firstName>
        <lastName>Kuster</lastName>
        <party>D</party>
        <state>NH</state>
        <middleName>M.</middleName>
        <district>2</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>B001303</bioguideId>
        <fullName>Rep. Blunt Rochester, Lisa [D-DE-At Large]</fullName>
        <firstName>Lisa</firstName>
        <lastName>Blunt Rochester</lastName>
        <party>D</party>
        <state>DE</state>
        <district>0</district>
        <sponsorshipDate>2023-06-12</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001119</bioguideId>
        <fullName>Rep. Craig, Angie [D-MN-2]</fullName>
        <firstName>Angie</firstName>
        <lastName>Craig</lastName>
        <party>D</party>
        <state>MN</state>
        <district>2</district>
        <sponsorshipDate>2023-06-12</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Congressional oversight</name>
          <updateDate>2023-11-13T13:45:33Z</updateDate>
        </item>
        <item>
          <name>Drug therapy</name>
          <updateDate>2023-11-13T13:45:33Z</updateDate>
        </item>
        <item>
          <name>Drug, alcohol, tobacco use</name>
          <updateDate>2023-11-13T13:45:33Z</updateDate>
        </item>
        <item>
          <name>Government studies and investigations</name>
          <updateDate>2023-11-13T13:45:33Z</updateDate>
        </item>
        <item>
          <name>Health care costs and insurance</name>
          <updateDate>2023-11-13T13:45:33Z</updateDate>
        </item>
        <item>
          <name>Health care coverage and access</name>
          <updateDate>2023-11-13T13:45:33Z</updateDate>
        </item>
        <item>
          <name>Medicaid</name>
          <updateDate>2023-11-13T13:45:33Z</updateDate>
        </item>
        <item>
          <name>Medicare</name>
          <updateDate>2023-11-13T13:45:33Z</updateDate>
        </item>
        <item>
          <name>Prescription drugs</name>
          <updateDate>2023-11-13T13:45:33Z</updateDate>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
        <updateDate>2023-07-14T20:14:22Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2023-06-12</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2023-11-01T15:09:59Z</updateDate>
        <text><![CDATA[ <p><b>Naloxone Affordability Act of 2023</b></p> <p>This bill requires the Government Accountability Office to study access to and affordability of naloxone (a medication that temporarily reverses opioid overdoses). The study must address matters related to out-of-pocket costs that consumers pay for naloxone and coverage for naloxone as an over-the-counter drug through Medicare, Medicaid, and private health insurance. </p> <p>Historically, naloxone required a prescription and so was typically covered by health insurance. However, the Food and Drug Administration approved Narcan (a naloxone hydrochloride nasal spray) for use without a prescription on March 29, 2023, and health insurance does not generally cover over-the-counter medications.</p> <p><br> </p>]]></text>
      </summary>
    </summaries>
    <title>Naloxone Affordability Act of 2023</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>Naloxone Affordability Act of 2023</title>
        <updateDate>2024-07-24T15:21:38Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Naloxone Affordability Act of 2023</title>
        <updateDate>2024-05-24T13:38:48Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>To direct the Comptroller General of the United States to conduct a study on naloxone access.</title>
        <updateDate>2024-03-18T20:59:23Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2023-06-12T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118hr4005ih/xml/BILLS-118hr4005ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2023-06-16</actionDate>
      <text>Referred to the Subcommittee on Health.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
